Consolidated Statements Of Income (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Net Sales	$ 3,194.3		$ 2,921.9	[1]	$ 2,749.3
Cost of sales	1,756.3		1,630.5		1,534.8
Gross Profit	1,438.0		1,291.4		1,214.5
Marketing expenses	399.8		357.3		354.1
Selling, general and administrative expenses	416.0		389.0		367.8
Income from Operations	622.2	[2]	545.1		492.6
Equity in earnings of affiliates	2.8		8.9		10.0
Investment earnings	2.6	[3]	1.7	[3]	1.9	[3]
Other income (expense), net	(2.1)	[3]	0.8	[3]	(1.2)	[3]
Interest expense	(27.7)	[3]	(14.0)	[3]	(8.7)	[3]
Income before Income Taxes	597.8		542.5		494.6
Income taxes	203.4		192.7		185.0
Net Income	$ 394.4		$ 349.8		$ 309.6
Weighted average shares outstanding-Basic	138.6		140.1		143.2
Weighted average shares outstanding-Diluted	141.2		142.7		145.8
Net Income per Share-Basic	$ 2.85		$ 2.50		$ 2.16	[4]
Net Income per Share-Diluted	$ 2.79		$ 2.45		$ 2.12	[4]
Cash dividends per share	$ 1.12		$ 0.96		$ 0.68

[1] The fourth quarter of 2012 Net Sales includes approximately $70 associated with the acquisition of the L'IL CRITTERS and VITAFUSION gummy vitamin dietary supplement business.

[2] The fourth quarter of 2013 Income from Operations includes approximately $6.5 of trade name impairment charges.

[3] In determining Income before Income Taxes, interest expense, investment earnings, and other income, net, were allocated to the segments based upon each segment's relative Income from Operations.

[4] The fourth quarter of 2011 Net Income and Net Income per Share includes a deferred tax valuation charge of approximately $13 (or $0.09 per share) and includes an additional month's results of three foreign subsidiaries due to the change in the fiscal calendar. The change increased net sales by $14.3, but had a nominal effect on net income.